4MIT image
Deposition Date 2013-09-02
Release Date 2014-09-03
Last Version Date 2023-09-20
Entry Detail
PDB ID:
4MIT
Title:
Crystal structure of E. histolytica RacC bound to the EhPAK4 PBD
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.35 Å
R-Value Free:
0.22
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Rho family GTPase
Mutations:Q65L
Chain IDs:A, B, C, D
Chain Length:186
Number of Molecules:4
Biological Source:Entamoeba histolytica
Polymer Type:polypeptide(L)
Molecule:Serine/threonine protein kinase PAK, putative
Gene (Uniprot):EHI7A_018700
Chain IDs:E, F, G, H
Chain Length:70
Number of Molecules:4
Biological Source:Entamoeba histolytica
Primary Citation
Entamoeba histolytica RacC Selectively Engages p21-Activated Kinase Effectors.
Biochemistry 54 404 412 (2015)
PMID: 25529118 DOI: 10.1021/bi501226f

Abstact

Rho family GTPases modulate actin cytoskeleton dynamics by signaling through multiple effectors, including the p21-activated kinases (PAKs). The intestinal parasite Entamoeba histolytica expresses ∼20 Rho family GTPases and seven isoforms of PAK, two of which have been implicated in pathogenesis-related processes such as amoebic motility and invasion and host cell phagocytosis. Here, we describe two previously unstudied PAK isoforms, EhPAK4 and EhPAK5, as highly specific effectors of EhRacC. A structural model based on 2.35 Å X-ray crystallographic data of a complex between EhRacC(Q65L)·GTP and the EhPAK4 p21 binding domain (PBD) reveals a fairly well-conserved Rho/effector interface despite deviation of the PBD α-helix. A structural comparison with EhRho1 in complex with EhFormin1 suggests likely determinants of Rho family GTPase signaling specificity in E. histolytica. These findings suggest a high degree of Rho family GTPase diversity and specificity in the single-cell parasite E. histolytica. Because PAKs regulate pathogenesis-related processes in E. histolytica, they may be valid pharmacologic targets for anti-amoebiasis drugs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures